Neither the Moderna nor the Pfizer stocks dropped very dramatically—both had solid upward trends throughout the past month, and the prices are already bouncing back. Investors make mistakes too.
Neither the Moderna nor the Pfizer stocks dropped very dramatically—both had solid upward trends throughout the past month, and the prices are already bouncing back. Investors make mistakes too.